Midmark Corporation partners with Cleveland Medical Devices Inc., introducing Portable Home Sleep Testing Monitor...

October 17, 2011 - Midmark Corporation partners with Cleveland Medical Devices Inc., introducing Portable Home Sleep Testing Monitor that enables patients to be tested for Obstructive Sleep Apnea in comfort of their own homes

- The FDA-cleared, physician-prescribed SleepView® provides a convenient and cost-effective alternative for diagnosing the most common type of breathing-related sleep disorder -

Midmark Corporation, a trusted leader in digital diagnostic devices for ambulatory care, announced a partnership with Cleveland Medical Devices, a leader in sleep diagnostics technology, launching the Midmark SleepView® Monitor and SleepViewSM Portal.

The Midmark SleepView Monitor developed by Cleveland Medical Devices is the market’s smallest and lightest portable home sleep monitor that meets the American Academy of Sleep Medicine’s recommended channel set for Type III monitors.

The Midmark SleepView Portal offers prescribing physicians secure, HIPAA compliant online access to registered polysomnographic technologists and board-certified sleep physicians who provide scoring, professional interpretation and treatment recommendations.

Obstructive sleep apnea (OSA) is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, 85 percent of the population with the disease is undiagnosed and untreated. "There is a real need in the healthcare industry to address this large and growing clinical concern," said Tom Treon, senior product manager for Midmark. "We want to improve the effectiveness and efficiency of care for patients with OSA by providing another diagnostic option, which enables patients to be tested in the comfort of their own bed and convenience of their own home for a more natural night of sleep."

OSA does in fact hold serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries. Economic studies have also shown that people with untreated OSA have 200 percent higher healthcare costs than similar people without OSA. Midmark has entered into a strategic partnership with Cleveland Medical Devices Inc. (CleveMed) for licensing of the SleepView technology. Established in 1990, CleveMed is a leader in sleep diagnostics technology with products serving sleep labs, institutional and home settings... Cleveland Medical Devices' press Release -

CleveMed : International Distribution by Obtaining Sleep Diagnostic Product Registrations in More Nations Overseas

May 22, 2009 – Cleveland Medical Devices Inc. (CleveMed) announced that it has registered its sleep diagnostic devices in Colombia, Taiwan, Singapore, Malaysia and the Philippines, opening the door to product distribution in these countries.

CleveMed’s Division of Sleep Disorders offers complete wireless PSG systems, such as the 14-channel Crystal Monitor® PSG Series and the 22-channel Sapphire PSG™. The SleepScout™ is a type III monitor for home sleep testing. All four systems include Crystal PSG™ software, a user-friendly software package for data acquisition, scoring and reporting that are used by clinicians in the diagnosis of sleep disorders. The Crystal Monitor 20-S, Crystal Monitor 20-B and Sapphire PSG systems can all be upgraded with the iPSG Inpatient PSG System to allow for remotely attended sleep studies in hospital rooms. Due to the systems' compact size, wireless design, fast and simple system setup and rearrangement, they are uniquely suited not just for studies in the traditional sleep lab setting, but also for nontraditional sleep applications such as hospital inpatient testing for pre-surgical evaluation, nursing homes, "hotel sleep labs" and patients' homes... CleveMed's Press Release -